Skip to content
contact@asploro.com
Asploro Open Access Publications
  • ABOUT
  • JOURNALS
    • Asploro Journal of Biomedical and Clinical Case Reports
    • Journal of Health Care and Research
    • Asploro Cardiovascular Case Reports and Research
    • Asploro Journal of Pediatrics and Child Health
    • Diabetes Research: Open Access
  • SUBMIT MANUSCRIPT
  • OPEN ACCESS
  • MEMBERSHIP
  • CONTACT US
  • LATEST POSTS
  • Toggle website search
Search this website Press Escape to close the search panel.
Menu Close
  • ABOUT
  • JOURNALS
    • Asploro Journal of Biomedical and Clinical Case Reports
    • Journal of Health Care and Research
    • Asploro Cardiovascular Case Reports and Research
    • Asploro Journal of Pediatrics and Child Health
    • Diabetes Research: Open Access
  • SUBMIT MANUSCRIPT
  • OPEN ACCESS
  • MEMBERSHIP
  • CONTACT US
  • LATEST POSTS
  • Toggle website search
Search this website

Rybelsus

A Diabetic Male with Metabolic Syndrome (Met-S) Treated by Low Carbohydrate Diet (LCD) and Oral Semaglutide

Continue ReadingA Diabetic Male with Metabolic Syndrome (Met-S) Treated by Low Carbohydrate Diet (LCD) and Oral Semaglutide

Rapid Reduction of HbA1c and Weight in Elderly Patient with Type 2 Diabetes (T2D) And Depression by Oral Semaglutide (Rybelsus) | Abstract

Continue ReadingRapid Reduction of HbA1c and Weight in Elderly Patient with Type 2 Diabetes (T2D) And Depression by Oral Semaglutide (Rybelsus) | Abstract

Useful Oral Administration of Glucagon-Like Peptide 1 Receptor Agonist (GLP-1RA) as Semaglutide (Rybelsus) for Type 2 Diabetes Mellitus (T2DM) | Abstract

Continue ReadingUseful Oral Administration of Glucagon-Like Peptide 1 Receptor Agonist (GLP-1RA) as Semaglutide (Rybelsus) for Type 2 Diabetes Mellitus (T2DM) | Abstract

End of content

No more pages to load

Useful Links

  • About UsOpens in a new tab
  • Latest ArticlesOpens in a new tab
  • Submit ManuscriptOpens in a new tab

Newsletter

Get all latest content delivered to your email a few times a month.
Email is required Email is not valid
Thanks for your subscription.
Failed to subscribe, please contact admin.
Asploro Open Access Publications
Copyright © 2026 Asploro Open Access Publications. All rights reserved where applicable.
Published articles, except where otherwise noted, are licensed under the Creative Commons Attribution 4.0 International License.
About Us Journals Submit Manuscript Contact
Loading Comments...